COVID-19 Self-testing Study
- Conditions
- COVID-19
- Interventions
- Behavioral: SMARTest mobile app for COVID-19 self-testing
- Registration Number
- NCT05701878
- Lead Sponsor
- Columbia University
- Brief Summary
The goal of this clinical trial is to understand how the introduction of an app-based intervention changes knowledge, attitudes, and practices on COVID-19 self-testing.
- Detailed Description
Rapid diagnostic testing has been shown to be an important tool in controlling the spread of the COVID-19 pandemic by identifying people when they are likely to be most contagious and reducing crowding at testing sites. In addition to employer-mandated testing, rapid antigen tests are becoming increasingly used by individuals. A method to promote frequent self-testing would help break the chain of viral transmission, slow the spread of disease, slow the spread of vaccine-resistant variants, and improve pandemic management.
The ubiquity of smartphones along with their data connectivity capabilities and onboard sensors make them an attractive tool to complement rapid diagnostic tests and an important component of decentralized testing. Smartphone-based tools have shown high acceptability among healthcare workers for the real-time tracking of rapid test results.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- English-speaking
- 18 years old or older
- Owns a smartphone running either Android or iOS operating systems
- Willing to download a COVID-19 self-testing app
- Willing to receive and send text messages for the study (and fill out surveys linked from text messages)
- Not willing to self-test themselves with COVID-19 rapid tests
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention (App) Group SMARTest mobile app for COVID-19 self-testing Participants in this group will be given access to a COVID-19 self-testing app (SMARTest). Access to the app, given exclusively to this group, will be in addition to the 12 COVID-19 self-test kits participants receive.
- Primary Outcome Measures
Name Time Method COVID-19 Self-Testing Knowledge, Attitudes, and Practices Questionnaire Score - study initiation Baseline COVID-19 Rapid Tests Knowledge, Attitudes, and Practices Questionnaire is a self-assessment measuring participant attitudes, knowledge, and practices toward COVID-19 rapid tests and self-testing.
COVID-19 Self-Testing Knowledge, Attitudes, and Practices Questionnaire Score - study completion At study completion (About 1 month after enrollment) COVID-19 Rapid Tests Knowledge, Attitudes, and Practices Questionnaire is a self-assessment measuring participant attitudes, knowledge, and practices toward COVID-19 rapid tests and self-testing.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
ICAP Harlem Prevention Center
🇺🇸New York, New York, United States